Tumor histopathology revealed the presence of a double tumor; a BRAF V600-mutated T4aN1bM0 papillary thyroid carcinoma and a squamous cell carcinoma of yet unknown primary origin, both located in the thyroid gland. Here, BRAF is linked to thyroid gland papillary carcinoma.